​This article was updated on January 5, 2023.

Independence Blue Cross (Independence) and Independence Administrators will make changes to their Select Drug Program^® Formulary and Value Formulary. The changes are effective January 1, 2023, and will include:

Changes in traditional glucose monitoring supplies

• Effective January 1, 2023, OneTouch^®​ produc​ts will no longer be the preferred brand test strip/meters on the Select Drug Program and on the Value Formulary.
• On the Select Drug Program, OneTouch^® and all non-Contour^® test strips will be non-preferred and will require prior authorization.
• On the Value Formulary, OneTouch^® and all non-Contour^® test strips will be non-formulary.

• Contour^® NEXT will be the preferred brand test strip/meters and will not require prior authorization.
• With the changes in preferred test strips, Independence is offering a free Contour^® Next One meter. The new meter can be used with the preferred brand Contour^® test strips.

Changes in continuous glucose monitoring (CGM) supplies

• Effective January 1, 2023, Freestyle Libre^® products will no longer be the preferred CGM on the Select Drug Program and on the Value Formulary.
• On the Select Drug Program, Freestyle Libre^® will be non-preferred and will require prior authorization.
• On the Value Formulary, Freestyle Libre^® will be non-formulary.
• Dexcom^®​ products will be the preferred CGM. Prior authorization continues to be required for Dexcom.
  

Review the changes that go into effect January 1, 2023:

• Independence Value Formulary with PA
• Independence Select Drug Program Formulary with PA
• Independence Administrators Select Drug Program Formulary without PA
• Independence Administrators Select Drug Program Formulary with PA

For more information on pharmacy policies and programs, visit the Independence Blue Cross and Independence Administrators websites.​